Decellularization and characterization of camel pericardium as a new scaffold for tissue engineering and regenerative medicine
- PMID: 38767039
- DOI: 10.1177/02184923241255720
Decellularization and characterization of camel pericardium as a new scaffold for tissue engineering and regenerative medicine
Abstract
Background: Valvular heart diseases (VHDs) have become prevalent in populations due to aging. Application of different biomaterials for cardiac valve regeneration and repair holds a great promise for treatment of VHD. Aortic valve replacement using tissue-engineered xenografts is a considered approach, and the pericardium of different species such as porcine and bovine has been studied over the last few years. It has been suggested that the animal origin can affect the outcomes of replacement.
Methods: So, herein, we at first decellularized and characterized the camel pericardium (dCP), then characterized dCP with H&E staining, in vitro and in vivo biocompatibility and mechanical tests and compared it with decellularized bovine pericardium (dBP), to describe the potency of dCP as a new xenograft and bio scaffold.
Results: The histological assays indicated less decluttering and extracellular matrix damage in dCP after decellularization compared to the dBP also dCP had higher Young Modulus (105.11), and yield stress (1.57 ± 0.45). We observed more blood vessels and also less inflammatory cells in the dCP sections after implantation.
Conclusions: In conclusion, the results of this study showed that the dCP has good capabilities not only for use in VHD treatment but also for other applications in tissue engineering and regenerative medicine.
Keywords: Valvular heart diseases; acellular; camel; pericardium; tissue engineering.
Conflict of interest statement
Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Intermediate-term outcomes of aortic valve replacement using a bioprosthesis with a novel tissue.J Thorac Cardiovasc Surg. 2021 Nov;162(5):1478-1485. doi: 10.1016/j.jtcvs.2020.01.095. Epub 2020 Feb 21. J Thorac Cardiovasc Surg. 2021. PMID: 32340804
-
Aortic Valve Replacement With Bovine Pericardial Tissue Valve in Children and Young Adults.Circulation. 2019 Feb 12;139(7):983-985. doi: 10.1161/CIRCULATIONAHA.118.037187. Circulation. 2019. PMID: 30742533 No abstract available.
-
Engineering of a polymer layered bio-hybrid heart valve scaffold.Mater Sci Eng C Mater Biol Appl. 2015 Jun;51:263-73. doi: 10.1016/j.msec.2015.03.009. Epub 2015 Mar 11. Mater Sci Eng C Mater Biol Appl. 2015. PMID: 25842134
-
Combining tissue repair and tissue engineering; bioactivating implantable cell-free vascular scaffolds.Heart. 2014 Dec;100(23):1825-30. doi: 10.1136/heartjnl-2014-306092. Epub 2014 Jul 22. Heart. 2014. PMID: 25053725 Review.
-
Decellularized tissue-engineered heart valves calcification: what do animal and clinical studies tell us?J Mater Sci Mater Med. 2020 Dec 5;31(12):132. doi: 10.1007/s10856-020-06462-x. J Mater Sci Mater Med. 2020. PMID: 33278023 Free PMC article. Review.
Cited by
-
Intramyocardial injection of pre-cultured endothelial progenitor cells and mesenchymal stem cells inside alginate/gelatin microspheres induced angiogenesis in infarcted rabbits.Cell Commun Signal. 2025 Jun 12;23(1):279. doi: 10.1186/s12964-025-02301-0. Cell Commun Signal. 2025. PMID: 40506721 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous